LGM
IOVA icon

Logos Global Management’s Iovance Biotherapeutics IOVA Stock Holding History

Logos Global Management’s Portfolio IOVA Stock Details IOVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Hold
0
– – – 65
2023
Q4 		– Hold
0
– – – 61
2023
Q3 		– Hold
0
– – – 66
2022
Q2 		– Sell
-1,000,000
Closed -$16.6M – 39
2022
Q1 		$16.6M Buy
+1,000,000
New +$15.5M 2.16% 19
2021
Q4 		– Sell
-500,000
Closed -$12.3M – 70
2021
Q3 		$12.3M Sell
500,000
-625,000
-56% -$14.7M 0.89% 30
2021
Q2 		$29.3M Buy
+1,125,000
New +$29.2M 2.51% 15
2020
Q2 		– Sell
-247,248
Closed -$7.4M – 55
2020
Q1 		$7.4M Buy
247,248
+26,705
+12% +$708K 2.84% 14
2019
Q4 		$6.11M Buy
+220,543
New +$5.02M 1.73% 21

Other funds holding IOVA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MFM
MHR Fund Management New York $1.37B AUM 68.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
PA
Perceptive Advisors New York $5.06B AUM 314.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $61.3B AUM 26.25% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.47T AUM 27.86% 1-Year Est. Return